T Cell Dysfunction in Cancer Immunity and Immunotherapy
In cancer, T cells become dysfunctional owing to persistent antigen exposure. Dysfunctional T cells are characterized by reduced proliferative capacity, decreased effector function, and overexpression of multiple inhibitory receptors. Due to the presence of various inhibitory signals in the complex...
Main Authors: | Anliang Xia, Yan Zhang, Jiang Xu, Tailang Yin, Xiao-Jie Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-07-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2019.01719/full |
Similar Items
-
Targeting the Tumor Microenvironment for Improving Therapeutic Effectiveness in Cancer Immunotherapy: Focusing on Immune Checkpoint Inhibitors and Combination Therapies
by: I-Tsu Chyuan, et al.
Published: (2021-03-01) -
Immune gene patterns and characterization of the tumor immune microenvironment associated with cancer immunotherapy efficacy
by: Lili Lin, et al.
Published: (2023-03-01) -
Editorial: Immune modulation in tumor microenvironment: New perspectives for cancer immunotherapy
by: Zimu Deng, et al.
Published: (2023-01-01) -
Extracellular Vesicles in Cancer Immune Microenvironment and Cancer Immunotherapy
by: Feng Xie, et al.
Published: (2019-12-01) -
Metabolic reprogramming of the tumor immune microenvironment in ovarian cancer: A novel orientation for immunotherapy
by: Yi Lin, et al.
Published: (2022-10-01)